Global Central Vascular Access Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028
“Global Central Vascular Access Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global central vascular access devices market report has been segmented on the basis of type, application, and region.
Global Central Vascular Access Devices Market: Overview
Vascular access devices are used for various applications such as intravenous antibiotic treatment or other medications, chemotherapy, long-term IV feeding, and blood transfusions. During the vascular access procedure, a flexible, sterile plastic tube is inserted into the blood vessel. This allows the doctor to drown blood or provide medication directly in the bloodstream of the patient. Vascular access aid in an easy and painless way to drawn blood and provide medication.
Global Central Vascular Access Devices Market: Dynamics
Rapid technological advancements in medical devices, an increasing number of surgeries across the globe is resulting in demand form advanced medical devices that aid in the administration of fluids, blood products, medication and other therapies to the bloodstream are major factors expected to drive growth of the global market.
In addition, rising number blood transfusions cases in developed countries and patient’s need for central venous access for various indications in long-term intravenous therapy such as antimicrobial therapy, fluid therapy, chemotherapy is another factor expected to further support market growth. According to National Center for Biotechnology Information, in the US around 15 Mn units of red blood cells are transfused per annually, while about 85 Mn units are transfused worldwide.
Moreover, increasing government spending on healthcare infrastructure in order to facilitate the adoption of advanced medical devices is expected to support market growth to a certain extent.
However, high cost of devices is a major factor expected to hamper growth of the global market. In addition, stringent government regulations related to product approval is another factor expected to challenge growth of the global market.
Technological advancements by major players for developing cost-effective medical devices is expected to create new opportunities in terms of revenue for players operating in the target market over the forecast period.
Global Central Vascular Access Devices Market: Segment
Among the type segments, the peripherally inserted central catheters segment is expected to dominate in the target market over the forecast period.
Among the application segments, the diagnostics & testing segment is expected to dominate in the target market over the forecast period.
Global Central Vascular Access Devices Market: Region
The market in North America is expected to dominate in the global market and is expected to continue its dominance over the forecast period. This can be attributed to developed healthcare infrastructure for easy adoption of advanced medical devices, and the presence of major manufacturers in countries in this region. In addition, strategic merger and acquisition activities between regional and international players are expected to further support target market growth in this region to a certain extent.
The market in Asia Pacific is expected to witness faster growth, owing to the increasing number of surgeries and the presence of prominent players operating in emerging economies such as China and India in this region. In addition, rising medical tourism in countries such as Malaysia and Singapore due to the low cost of surgeries and the availability of advanced healthcare facilities is expected to further support the growth of the market in this region.
Global Central Vascular Access Devices Market Segmentation
Segment by type
- Peripherally inserted central catheters (PICC)
- Tunneled catheters
- Non tunneled catheters
- Implanted ports
Segment by application
- Drug administration
- Fluid and nutrition administration
- Blood transfusion
- Diagnostics & testing
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Becton, Dickinson and Company
- R. Bard, Inc.
- Smiths Medical, Inc.
- Teleflex Incorporated
- Braun Melsungen AG
- NIPRO Medical Corporation
- Edwards Lifesciences Corporation
- Terumo Corporation
- Vygon Ltd.
- Ameco Medical Industries
- AngioDynamics, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!